Professor Kamlesh Khunti

Professor of Primary Care Diabetes and Vascular Medicine  

Profile

Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He has led a programme of work during the COVID-19 pandemic and is a member of UK Government's Scientific Advisory Group for Emergencies (SAGE) and Chair of the SAGE Ethnicity Sub-panel.

Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) in Applied Research Collaborations (ARC) East Midlands, Director of Centre for Ethnic Health Research and Director of The Real World Evidence Unit. He has published over 1100 peer-reviewed articles. He is also Honorary Visiting Professorial Fellow with Department of General Practice, University of Melbourne.

He is named as Top T2 diabetes researcher globally by Expertscape. He has won numerous awards nationally and internationally, including ‘Sardar Vallabhbhai Patel Award for Excellence in Medical Research, India’, ‘Primary Care Diabetes Society Lifetime Achievement Award’, ‘Diabetes Philippines Augusto D. Litonjua Endowed Lecture Award’, ‘Primary Care Diabetes Europe Paul Cromme Award’.

He was awarded the CBE in the 2022 New Year’s Honour’s List for services to health. 

Research

  • Cardiometabolic disease
  • Prevention of multimorbidity
  • Prevention of Cardiometabolic Diseases.
  • Risk Assessment Tools
  • Ethnic Minority Health
  • Real World Evidence
  • Randomised Controlled Trials

Publications

See more of Professor Khunti's publications via Google Scholar.

1104. Pearson N, Griffiths P, van Sluijs E, Atkin AJ, Khunti K, Sherar LB. Associations between socioeconomic position and young people's physical activity and sedentary behaviour in the UK: a scoping review. BMJ Open 2022 May 2; 12(5):e051736. Doi: 10.1136/bmjopen-2021-051736.PMID: 35501089

1103. Zaccardi F, Kloecker DE, Khunti K, Davies MJ. Noninferiority and clinical superiority of GLP-1 receptor agonists and SGLT2 inhibitors: systematic analysis of cardiorenal outcome trials in type 2 diabetes. Diabetes Obes Metab 2022 May 1. Doi: 10.1111/dom.14735. Online ahead of print. PMID: 35491523

1102. Ho IS, Azcoaga-Lorenzo A, Akbari A, Davies J, Hodgins P, Khunti K, Kadam U, Lyons R, McCowan C, Mercer SW, Nirantharakumar K, Guthrie B. Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies. BMJ Open 2022 Apr 29; 12(4):e057017. Doi: 10.1136/bmjopen-2021-057017.PMID: 35487738

1101. Arnold SV, Tang F, Cooper A, Chen H, Gomes MB, Rathmann W, Shimomura I, Vora J, Watada H, Khunti K, Kosiborod M. Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER. BMC Endocr Disord 2022 Apr 26; 22(1):111. Doi:10.1186/s12902-022-01026-2.PMID: 35473607

1100. PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022 Apr 22. Doi: 10.1016/S2213-2600(22)00127-8. Online ahead of print. PMID: 35472304

1099. Harris S, Ruan Y, Wild SH, Wargny M, Hadjadj S, Delasalle B, Saignes M, RyderRE, Field BCT, Narendran P, Zaccardi F, Wilmot EG, Vlacho B, Llauradó G,Mauricio D, Nagi D, Patel D, Várnai KA, Davies J, Gourdy P, Cariou B, Rea R, Khunti K; CORONADO, the ABCD COVID-19 diabetes national audit and HM Hospitales investigators. Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study. Diabetes Metab Syndr 2022 Apr 11; 16(5):102484. Doi: 10.1016/j.dsx.2022.102484. Online ahead of print. PMID: 35472685

1098. Dolby T, Finning K, Baker A, Fowler-Dowd L, Khunti K, Razieh C, Yates T, Nafilyan V. Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England : a national linked data set. J Epidemiol Community Health 2022Apr 25. Doi: 10.1136/jech-2021-218415. Online ahead of print. PMID: 35470259

1097. Kerr D, Edelman S, Vespasiani G, Khunti K. New digital health technologies for insulin initiation and optimization for people with type 2 diabetes. Endocr Pract 2022 Apr 19. Doi: 10.1016/j.eprac.2022.04.006. Online ahead of print. PMID: 35452813

1096. Dempsey PC, Musicha C, Rowlands AV, Davies M, Khunti K, Razieh C, Timmins I, Zaccardi F, Codd V, Nelson CP, Yates T, Samani NJ. Investigation of a UK biobank cohort reveals causal associations of self-reported walking pace with telomere length. Commun Biol 2022 Apr 20;5(1):381. Doi: 10.1038/s42003-022-03323-x.PMID: 35444173

1095. Olson J, Hadjiconstantinou M, Luff C, Watts K, Watson N, Miller V, Schofield D, Khunti K, Davies MJ, Calginari S. From the United Kingdom to Australia-Adapting a Web-Based Self-management Education Program to Support the Management of Type 2 Diabetes: Tutorial. J Med Internet Res 2022 Apr 20; 24(4):e26339. Doi:10.2196/26339.PMID: 35442198

COVID-19 publications

167. Salari N, Vepa A, Daneshkhah A, Darvishi N, Ghasemi H, Khunti K, Mohammadi M. Efficacy of COVID-19 vaccines by race and ethnicity. Public Health. 2022 May 5; 208:14-17. Doi: 10.1016/j.puhe.2022.04.009. Online ahead of print.PMID: 35660280

166. Valabhji J, Barron E, Gorton T, Bakhai C, Kar P, Young B, Khunti K, Holman N, Sattar N, Wareham NJ. Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study. Lancet Diabetes Endocrinol 2022 May 27:S2213-8587(22)00131-0. Doi: 10.1016/S2213-8587(22)00131-0. Online ahead of print.PMID: 35636440

165. O'Mahoney LL, Highton PJ, Kudlek L, Morgan J, Lynch R, Schofield E, Sreejith N,  Kapur A, Otunla A, Kerneis S, James O, Rees K, Curtis F, Khunti K, Hartmann- Boyce J. The impact of the Covid-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2022 May 23. Doi: 10.1111/dom.14771. Online ahead of print.PMID: 35603919

164. Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, Khunti K, Alwan NA, Walker AS. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022 May 18; 377:e069676. Doi: 10.1136/bmj-2021-069676.PMID: 35584816

163. PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022 Apr 22. Doi: 10.1016/S2213-2600(22)00127-8. Online ahead of print.PMID: 35472304 

162. Harris S, Ruan Y, Wild SH, Wargny M, Hadjadj S, Delasalle B, Saignes M, Ryder RE, Field BCT, Narendran P, Zaccardi F, Wilmot EG, Vlacho B, Llauradó G, Mauricio D, Nagi D, Patel D, Várnai KA, Davies J, Gourdy P, Cariou B, Rustom R, Khunti K; CORONADO, the ABCD COVID-19 diabetes national audit and HM  Hospitales investigators. Association of statin and/or renin-angiotensin-aldosterone  system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study. Diabetes Metab Syndr 2022 Apr 11; 16(5):102484. Doi: 10.1016/j.dsx.2022.102484. Online ahead of print.PMID: 35472685

161. Dolby T, Finning K, Baker A, Fowler-Dowd L, Khunti K, Razieh C, Yates T,  Nafilyan V. Monitoring sociodemographic inequality in COVID-19 vaccination  uptake in England : a national linked data set. J Epidemiol Community Health 2022    Apr 25. Doi: 10.1136/jech-2021-218415. Online ahead of print.PMID: 35470259

160. Chandan JS, Brown K, Simms-Williams N, Camaradou J, Bashir N, Heining D,   Aiyegbusi OL, Turner G, Cruz Rivera S, Hotham R, Nirantharakumar K, Sivan M, Khunti K, Raindi D, Marwaha S, Hughes SE, McMullan C, Calvert M, Haroon S. Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol. BMJ Open 2022 Apr 11; 12(4):e057885. Doi: 10.1136/bmjopen-2021-057885.PMID: 35410933

159. Norris T, Razieh C, Yates T, Zaccardi F, Gillies CL, Chudasama YV, Rowlands A, Davies MJ, McCann GP, Banerjee A, Docherty AB, Openshaw PJM, Baillie JK, Semple MG, Lawson CA, Khunti K. Admission Blood Glucose Level and Its Association With Cardiovascular and Renal Complications in patients Hospitalized With Covid-19. Diabetes Care 2022 Mar 11. Doi: 10.2337/dc21-1709. Online ahead of print.PMID: 35275994

158. Lyons J, Nafilyan V, Akbari A, Davies G, Griffiths R, Harrison EM, Hippisley-Cox J, Hollinghurst J, Khunti K, North L, Sheikh A, Torabi F, Lyons RA. Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK. Int J Popul Data Sci 2022 Feb 15;5(4):1697. Doi: 10.23889/ijpds.v5i4.1697. eCollection 2020.PMID: 35310465 

Supervision

  1. Meri Everitt, January 2022
    Title of PhD: PhD Studentship: Evaluation and development of methodologies for using real world evidence to investigate the results of randomised controlled trials, utilising COVID-19 vaccine trials as a worked example

  2. Ellen Hopwood, 2021
    Title: Self-management support in patients with multiple long-term conditions in the post-COVID-19 era.

  3. Daniel Ayoubkhani, 2021,Office of National statistics, UK (ONS)
    Title : Exploring the epidemiology and outcomes of post- COVID-19 syndrome using national linked data.

  4. Hanad Osman, July 2021
    Title :A comparative analysis of a novel biochemical urine screen with pharmacy prescription records and a self- reported questionnaire to assess non-adherence in people with type 2 diabetes mellitus

  5. Danielli Mariana, March 2020
    Title : Role of perivascular biomarkers at the fetal-maternal interface in pre-eclampsia and fetal growth restriction.

  6. Dan Lane, September 2018
    Title : Developments of biochemical methods to diagnose non-adherence in cardiometabolic diseases and their clinical utility

  7. Elpida Vounzoulaki September 2018
    Title : Type 2 diabetes in women after a diagnosis of gestational diabetes: understanding uptake to screening, progression rates and costs, using evidence synthesis methodologies

  8. Humaira Hussein September 2017
    Title : Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus: randomized and real-word evidence

Press and media

Media enquiries

Get in touch for media enquiries, expert opinion, interviews, images or video.

Back to top
arrow-downarrow-down-3arrow-down-2arrow-down-4arrow-leftarrow-left-3arrow-left-2arrow-leftarrow-left-4arrow-rightarrow-right-3arrow-right-2arrow-right-4arrow-uparrow-up-3arrow-up-2arrow-up-4book-2bookbuildingscalendar-2calendarcirclecrosscross-2facebookfat-l-1fat-l-2filtershead-2headinstagraminstagraminstagramlinkedinlinkedinmenuMENUMenu Arrowminusminusrotator-pausec pausepinrotator-playplayc playplussearchsnapchatsnapchatthin-l-1thin-l-2ticktweettwittertwittertwitterwechatweiboweiboyoutubeyoutube